![[Adobe Stock]](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_750,h_375/https://www.psypost.org/wp-content/uploads/2025/05/neurons-4-750x375.jpg)
Recent research published in Circulation Research provides evidence that a specific molecule produced by gut bacteria can protect the heart from stiffness and dysfunction by communicating directly with the brain. The study suggests that restoring this bacterial by-product might offer a new way to approach high blood pressure and related heart conditions.
Hypertension and related cardiovascular conditions involve a complex interaction among the digestive, nervous, and cardiovascular systems. High blood pressure tends to force the heart muscle to become stiff and lose its ability to relax properly between beats, a condition known as diastolic dysfunction. This stiffness represents a major physiological cause of heart failure, but the biological signals that initiate this structural change remain poorly understood.
To understand this process, researchers aimed to identify the chemical messengers that link these physiological systems. “Hypertension is a systemic condition driven by complex interactions between the gut, brain, kidneys, and cardiovascular system,” said study author Suphansa Sawamiphak, a principal investigator at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association in Berlin, Germany.
“While we knew that high blood pressure is associated with gut dysbiosis and often compromises the heart’s ability to relax, the precise molecular signals linking these systems were missing. We wanted to bridge this gap and identify the specific microbial metabolites that mediate this interorgan communication during hypertensive stress.”
To study this biological connection, the scientists used a specialized zebrafish model. Zebrafish larvae are largely transparent, allowing researchers to observe their beating hearts and circulating blood in real time using high-speed microscopes. The team induced high blood pressure in the larvae by rearing them in water with progressively lower salt concentrations over five days. This low-ion environment forced the fish to activate internal hormonal mechanisms to retain sodium, which in turn increased their blood pressure and caused their heart muscles to stiffen.
The researchers first analyzed the gut bacteria of the zebrafish after the five-day hypertensive challenge. By sequencing the genetic material of the bacteria in the digestive tracts of ten treated groups and eleven control groups, they found a marked decrease in overall bacterial diversity. The stressed fish lost specific bacteria responsible for breaking down tryptophan, an amino acid found in food, into indole molecules.
The team then tested whether the presence of gut bacteria was necessary to protect the heart. They raised groups of eight to twelve germ-free zebrafish, meaning the fish completely lacked any gut microbes. When exposed to the same low-salt stress, these germ-free fish exhibited more severe blood pressure spikes and worsened heart stiffness compared to fish with normal gut bacteria. This finding provides evidence that a healthy microbial community helps shield the cardiovascular system from damage.
Next, the researchers examined the specific chemical by-products produced by the gut bacteria. Using mass spectrometry, a specialized laboratory technique that measures the mass and concentration of different molecules, they analyzed the intestines of the fish. They found that the stressed fish had significantly lower levels of indole-3 acetic acid, a specific byproduct of tryptophan metabolism, compared to healthy fish.
This depletion of beneficial molecules has a cascading effect on the body’s stress response. “Our gut microbiome actively protects the heart during hypertensive challenges by producing specific molecules, notably Indole-3 Acetic Acid (IAA), derived from dietary tryptophan,” Sawamiphak explained. “When high blood pressure disrupts the microbiome, the resulting loss of IAA removes a brake on the brain’s stress signaling, specifically within hypocretin-producing neurons. This missing brake leads to sympathetic overdrive, compromising the heart muscle’s ability to properly relax between beats (diastolic dysfunction).”
To see if replacing this missing molecule could help, the scientists administered indole-3 acetic acid directly into the digestive tracts of the fish. Fish that received this supplement maintained normal blood pressure and healthy heart function, even when exposed to the low-salt stress. The treatment prevented the individual heart muscle cells from enlarging and kept the main pumping chambers of the heart relaxing normally between beats.
The researchers then looked at the brain to understand how a gut molecule could protect the heart. They focused on hypocretin neurons, a specialized group of brain cells in the hypothalamus that help regulate involuntary functions like heart rate and blood vessel constriction. Using special fluorescent markers that light up when neurons are active, they observed that the hypocretin neurons became highly overactive during the hypertensive stress. Giving the fish indole-3 acetic acid quieted these brain cells back to normal baseline levels.
Further experiments revealed exactly how the molecule influenced the brain. The scientists found that hypocretin neurons possess a specific chemical sensor called the aryl hydrocarbon receptor. When they injected indole-3 acetic acid directly into the brain cavities of the fish, it activated this receptor and protected the heart from stiffening. If they blocked the receptor with a chemical inhibitor, the protective effects completely disappeared.
By preventing the hypocretin neurons from becoming overactive, the indole-3 acetic acid stopped an excessive cascade of nervous system signals from reaching the heart. Using a technique called calcium imaging to monitor nerve activity in live fish, the team saw that the treatment calmed the sympathetic nervous system, which is the network responsible for the body’s physical responses to stress. The treatment also lowered the systemic levels of hormones that constrict blood vessels, acting on multiple fronts to protect the cardiovascular system.
To determine if these findings translate to humans, the researchers analyzed blood samples from a cohort of 194 individuals under the age of fifty. This group included 97 patients with high blood pressure and 97 healthy individuals, matched for age, sex, and body mass index. The scientists found that the patients with hypertension had significantly lower levels of indole-3 acetic acid in their blood.
This clinical data strongly mirrored the physiological changes observed in the animal models. “We were struck by how potently a single microbial metabolite, IAA, could act centrally in the brain to simultaneously prevent both neurogenic (sympathetic overdrive) and hormonal (renin-angiotensin system) drivers of hypertension,” Sawamiphak said. “Furthermore, finding that this specific depletion of circulating IAA is strongly conserved in a human hypertensive cohort, with a particularly pronounced sex-specific reduction in female patients, was a remarkable validation of our zebrafish model.”
While the study provides substantial evidence for a gut-brain-heart connection, it has some limitations. Zebrafish models offer a simplified view of biology and do not capture the full complexity of human aging or metabolic diseases that often accompany heart problems. The human data used in the study is observational, meaning it shows a link between low indole-3 acetic acid and high blood pressure but does not prove that one causes the other in people.
The authors caution against viewing these results as an immediate clinical treatment. “It is important not to misinterpret these findings as evidence that simply taking an over-the-counter IAA or tryptophan supplement is a standalone cure for high blood pressure,” Sawamiphak noted. “While we established a direct cause-and-effect mechanism in our animal models, the human data we analyzed is currently correlational. Hypertension is a highly complex, multifactorial disease, and IAA deficiency represents one component of a much broader systemic dysregulation.”
Future studies are needed to determine if restoring this molecule can safely and effectively treat or prevent heart disease in human patients. “Our immediate next step is to understand exactly how microbial metabolites like IAA regulate neuronal activity at a molecular level,” Sawamiphak said. “Beyond IAA, we are also examining a broader range of microbial metabolites that shift during disease states, particularly those known to regulate the immune system.”
The long-term objective is to map out these complex biological interactions to pave the way for medical advancements. “Ultimately, our overarching goal is to decode this complex, system-wide communication network between the gut, the brain, the immune system, and the heart,” Sawamiphak explained.
“While our laboratory focuses on fundamental biological discovery rather than conducting human clinical trials, pinpointing these precise disease mechanisms and molecular targets provides the essential foundation. It allows clinical researchers to eventually develop targeted therapies, such as postbiotics that deliver the exact missing beneficial molecules, to restore balance in cardiovascular and metabolic diseases.”
The study, “Indole-3 Acetate Limits Dysbiosis-Driven Diastolic Failure via Hcrt Neurons,” was authored by Bhakti I. Zakarauskas-Seth, Giovanni Forcari, Harithaa Anandakumar, Ilan Kotlar-Goldaper, Clara M. Barraud, Nina Jovanovic, Ulrike Brüning, Jennifer A. Kirwan, Nicola Wilck, Sofia K. Forslund, Dominik N. Müller, Alessandro Filosa, and Suphansa Sawamiphak.